Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

LncRNAs may help improve brain cancer treatment and diagnosis.

Deleting Twist1 in skin cells reduces UVB-induced skin cancer risk.

A parasite molecule can speed up skin healing and reduce scarring.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Epidermal growth factor disrupts hair and gland formation in bandicoots.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Inhibiting ODC can prevent UV-induced skin cancer.

Early changes in skin gene expression can predict later bone mass loss after radiation exposure.

The glucocorticoid receptor helps protect skin from tumors and other issues.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

PTHrP is higher in certain dog tumors and may act as a local growth factor.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The analysis of a large pilomatricoma revealed five distinct areas with different gene activity related to hair growth and tumor development.

Inactive hair follicle stem cells help prevent skin cancer.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

A man had a non-cancerous, fast-growing skin lump on his arm that was removed with surgery.

SVpgC2a cells show abnormal growth and keratin changes, modeling early cancer development.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Trichogerminoma is a rare, benign skin tumor from hair cells, with a small risk of becoming cancerous.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

VEGF gel increases hair growth but may have potential toxicity.